Social and Economic Costs of Attention-Deficit/Hyperactivity Disorder Across the Lifespan,Journal of Attention Disorders

当前位置： X-MOL 学术 › J. Atten. Disord. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Social and Economic Costs of Attention-Deficit/Hyperactivity Disorder Across the Lifespan
Journal of Attention Disorders ( IF 3 ) Pub Date : 2020-10-13 , DOI: 10.1177/1087054720961828
Emma Sciberras _{1,

2,

3} , Jared Streatfeild ₄ , Tristan Ceccato ₄ , Lynne Pezzullo ₄ , James G Scott _{5,

6,

7} , Christel M Middeldorp _{8,

9,

10} , Paul Hutchins _{11,

12} , Roger Paterson ₁₃ , Mark A Bellgrove ₁₄ , David Coghill _{2,

3}

Affiliation

Deakin University, Geelong, VIC, Australia.
Murdoch Children's Research Institute, Parkville, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.
Deloitte Access Economics Pty Ltd, Canberra, Australian Capital Territory, Australia.
Metro North Mental Health Service, Herston, Brisbane, QLD, Australia.
QIMRB Research Institute Herston, Brisbane, QLD, Australia.
Queensland Centre for Mental Health Research, Wacol, QLD, Australia.
University of Queensland, Brisbane, QLD, Australia.
Children's Health Queensland Hospital and Health Service, Brisbane, Australia.
Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Children's Hospital at Westmead, Westmead, NSW, Australia.
University of Sydney, NSW, Australia.
Hollywood Specialist Centre, Nedlands, Western Australia, Australia.
Monash University, Melbourne, VIC, Australia.

Objective:

To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan.

Method:

The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)).

Results:

The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion).

Conclusion:

There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.

中文翻译：